EBS
Price
$6.99
Change
-$0.12 (-1.69%)
Updated
Jul 3 closing price
Capitalization
120.07M
39 days until earnings call
SBFM
Price
$1.55
Change
-$0.10 (-6.06%)
Updated
Jul 3 closing price
Capitalization
6.02M
26 days until earnings call
Interact to see
Advertisement

EBS vs SBFM

Header iconEBS vs SBFM Comparison
Open Charts EBS vs SBFMBanner chart's image
Emergent Biosolutions
Price$6.99
Change-$0.12 (-1.69%)
Volume$917.38K
Capitalization120.07M
Sunshine Biopharma
Price$1.55
Change-$0.10 (-6.06%)
Volume$292.84K
Capitalization6.02M
EBS vs SBFM Comparison Chart in %
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. SBFM commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a Buy and SBFM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (EBS: $6.99 vs. SBFM: $1.55)
Brand notoriety: EBS and SBFM are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EBS: 72% vs. SBFM: 199%
Market capitalization -- EBS: $120.07M vs. SBFM: $6.02M
EBS [@Pharmaceuticals: Other] is valued at $120.07M. SBFM’s [@Pharmaceuticals: Other] market capitalization is $6.02M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, EBS is a better buy in the long-term than SBFM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 3 TA indicator(s) are bullish while SBFM’s TA Score has 7 bullish TA indicator(s).

  • EBS’s TA Score: 3 bullish, 3 bearish.
  • SBFM’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SBFM is a better buy in the short-term than EBS.

Price Growth

EBS (@Pharmaceuticals: Other) experienced а +2.34% price change this week, while SBFM (@Pharmaceuticals: Other) price change was +5.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

EBS is expected to report earnings on Aug 12, 2025.

SBFM is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EBS($120M) has a higher market cap than SBFM($6.02M). EBS has higher P/E ratio than SBFM: EBS (17.73) vs SBFM (0.88). EBS YTD gains are higher at: -26.883 vs. SBFM (-48.333). SBFM has higher annual earnings (EBITDA): -26.1M vs. EBS (-518.2M). EBS has more cash in the bank: 112M vs. SBFM (18.8M). SBFM has less debt than EBS: SBFM (674K) vs EBS (860M). EBS has higher revenues than SBFM: EBS (1.02B) vs SBFM (20.4M).
EBSSBFMEBS / SBFM
Capitalization120M6.02M1,994%
EBITDA-518.2M-26.1M1,985%
Gain YTD-26.883-48.33356%
P/E Ratio17.730.882,023%
Revenue1.02B20.4M5,015%
Total Cash112M18.8M596%
Total Debt860M674K127,596%
FUNDAMENTALS RATINGS
EBS vs SBFM: Fundamental Ratings
EBS
SBFM
OUTLOOK RATING
1..100
481
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
4764
P/E GROWTH RATING
1..100
1188
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (37) in the null industry is in the same range as EBS (57) in the Biotechnology industry. This means that SBFM’s stock grew similarly to EBS’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as EBS (100) in the Biotechnology industry. This means that SBFM’s stock grew similarly to EBS’s over the last 12 months.

SBFM's SMR Rating (94) in the null industry is in the same range as EBS (94) in the Biotechnology industry. This means that SBFM’s stock grew similarly to EBS’s over the last 12 months.

EBS's Price Growth Rating (47) in the Biotechnology industry is in the same range as SBFM (64) in the null industry. This means that EBS’s stock grew similarly to SBFM’s over the last 12 months.

EBS's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for SBFM (88) in the null industry. This means that EBS’s stock grew significantly faster than SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSSBFM
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFRTF5.610.13
+2.29%
Nexus Industrial REIT
ALFVY42.870.08
+0.19%
Alfa-Laval AB
SMNUF0.03N/A
N/A
Pt Sarana Menara Nusantara, Tbk
DVHGF0.18N/A
N/A
Devonian Health Group Inc.
FNMCF0.29-0.01
-3.99%
FIRST NORDIC METALS CORP.

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and TLRY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-6.06%
TLRY - SBFM
27%
Poorly correlated
+11.03%
ELAN - SBFM
24%
Poorly correlated
-0.54%
LFCR - SBFM
23%
Poorly correlated
N/A
EBS - SBFM
23%
Poorly correlated
-1.69%
CGC - SBFM
22%
Poorly correlated
+7.56%
More